1
|
Matias I, Diniz LP, Araujo APB, Damico IV, de Moura P, Cabral-Miranda F, Diniz F, Parmeggiani B, de Mello Coelho V, Leite REP, Suemoto CK, Ferreira GC, Kubrusly RCC, Gomes FCA. Age-Associated Upregulation of Glutamate Transporters and Glutamine Synthetase in Senescent Astrocytes In Vitro and in the Mouse and Human Hippocampus. ASN Neuro 2023; 15:17590914231157974. [PMID: 36815213 PMCID: PMC9950616 DOI: 10.1177/17590914231157974] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023] Open
Abstract
Aging is marked by complex and progressive physiological changes, including in the glutamatergic system, that lead to a decline of brain function. Increased content of senescent cells in the brain, such as glial cells, has been reported to impact cognition both in animal models and human tissue during normal aging and in the context of neurodegenerative disease. Changes in the glutamatergic synaptic activity rely on the glutamate-glutamine cycle, in which astrocytes handle glutamate taken up from synapses and provide glutamine for neurons, thus maintaining excitatory neurotransmission. However, the mechanisms of glutamate homeostasis in brain aging are still poorly understood. Herein, we showed that mouse senescent astrocytes in vitro undergo upregulation of GLT-1, GLAST, and glutamine synthetase (GS), along with the increased enzymatic activity of GS and [3H]-D-aspartate uptake. Furthermore, we observed higher levels of GS and increased [3H]-D-aspartate uptake in the hippocampus of aged mice, although the activity of GS was similar between young and old mice. Analysis of a previously available RNAseq dataset of mice at different ages revealed upregulation of GLAST and GS mRNA levels in hippocampal astrocytes during aging. Corroborating these rodent data, we showed an increased number of GS + cells, and GS and GLT-1 levels/intensity in the hippocampus of elderly humans. Our data suggest that aged astrocytes undergo molecular and functional changes that control glutamate-glutamine homeostasis upon brain aging.
Collapse
Affiliation(s)
- Isadora Matias
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil, Isadora Matias, Instituto de Ciências
Biomédicas, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde,
Bloco F, Ilha do Fundão, 21941-902 - Rio de Janeiro, RJ, Brasil.
| | - Luan Pereira Diniz
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil
| | - Ana Paula Bergamo Araujo
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil
| | - Isabella Vivarini Damico
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil
| | - Pâmella de Moura
- Instituto Biomédico, Universidade Federal
Fluminense, Niterói, Brasil
| | - Felipe Cabral-Miranda
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil
| | - Fabiola Diniz
- Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil,Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil
| | - Belisa Parmeggiani
- Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil
| | - Valeria de Mello Coelho
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil
| | - Renata E. P. Leite
- Biobanco para Estudos em Envelhecimento, Faculdade de Medicina da Universidade de
São Paulo, São Paulo, Brasil,Divisão de Geriatria, Faculdade de Medicina da Universidade de São
Paulo, São Paulo, Brasil
| | - Claudia K. Suemoto
- Divisão de Geriatria, Faculdade de Medicina da Universidade de São
Paulo, São Paulo, Brasil
| | - Gustavo Costa Ferreira
- Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil
| | | | - Flávia Carvalho Alcantara Gomes
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, Brasil,Flávia Carvalho Alcantara Gomes. Instituto
de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Centro de
Ciências da Saúde, Bloco F, Ilha do Fundão, 21941-902 - Rio de Janeiro, RJ,
Brasil.
| |
Collapse
|
2
|
Kubrusly RCC, da Rosa Valli T, Ferreira MNMR, de Moura P, Borges-Martins VPP, Martins RS, Ferreira DDP, Sathler MF, de Melo Reis RA, Ferreira GC, Manhães AC, Dos Santos Pereira M. Caffeine Improves GABA Transport in the Striatum of Spontaneously Hypertensive Rats (SHR). Neurotox Res 2021; 39:1946-1958. [PMID: 34637050 DOI: 10.1007/s12640-021-00423-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Revised: 09/25/2021] [Accepted: 09/27/2021] [Indexed: 11/28/2022]
Abstract
The spontaneously hypertensive rat (SHR) is an excellent animal model that mimics the behavioral and neurochemical phenotype of attention-deficit/hyperactivity disorder (ADHD). Here, we characterized the striatal GABA transport of SHR and investigated whether caffeine, a non-selective antagonist of adenosine receptors, could influence GABAergic circuitry. For this purpose, ex vivo striatal slices of SHR and Wistar (control strain) on the 35th postnatal day were dissected and incubated with [3H]-GABA to quantify the basal levels of uptake and release. SHR exhibited a reduced [3H]-GABA uptake and release, suggesting a defective striatal GABAergic transport system. GAT-1 appears to be the primary transporter for [3H]-GABA uptake in SHR striatum, as GAT-1 selective blocker, NO-711, completely abolished it. We also verified that acute exposure of striatal slices to caffeine improved [3H]-GABA uptake and release in SHR, whereas Wistar rats were not affected. GABA-uptake increase and cAMP accumulation promoted by caffeine was reverted by A1R activation with N6-cyclohexyl adenosine (CHA). As expected, the pharmacological blockade of cAMP-PKA signaling by H-89 also prevented caffeine-mediated [3H]-GABA uptake increment. Interestingly, a single caffeine exposure did not affect GAT-1 or A1R protein density in SHR, which was not different from Wistar protein levels, suggesting that the GAT-1-dependent transport in SHR has a defective functional activity rather than lower protein expression. The current data support that caffeine regulates GAT-1 function and improves striatal GABA transport via A1R-cAMP-PKA signaling, specifically in SHR. These results reinforce that caffeine may have therapeutic use in disorders where the GABA transport system is impaired.
Collapse
Affiliation(s)
| | | | | | - Pâmella de Moura
- Laboratório de Neurofarmacologia, Instituto Biomédico, Niterói, RJ, Brazil
| | | | - Robertta Silva Martins
- Laboratório de Neurofarmacologia, Instituto Biomédico, Niterói, RJ, Brazil
- Laboratório de Neurobiologia Celular E Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil
| | | | | | - Ricardo Augusto de Melo Reis
- Laboratório de Neuroquímica, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Gustavo Costa Ferreira
- Laboratório de Neuroenergética E Erros Inatos Do Metabolismo, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Alex Christian Manhães
- Laboratório de Neurofisiologia, Instituto de Biologia, Universidade Do Estado Do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Maurício Dos Santos Pereira
- Laboratório de Neurofarmacologia, Instituto Biomédico, Niterói, RJ, Brazil.
- Laboratório de Neurofisiologia Molecular, Departamento de Biologia Básica E Oral, Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
| |
Collapse
|
3
|
de Santana Souza L, de Siqueira PA, Fernandes A, Silva Martins R, Cussa Kubrusly RC, Paes-de-Carvalho R, Cunha RA, Dos Santos-Rodrigues A, Pandolfo P. Role of Neuropeptide S on Behavioural and Neurochemical Changes of an Animal Model of Attention-Deficit/Hyperactivity Disorder. Neuroscience 2020; 448:140-148. [PMID: 32976984 DOI: 10.1016/j.neuroscience.2020.09.030] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2020] [Revised: 09/06/2020] [Accepted: 09/10/2020] [Indexed: 10/23/2022]
Abstract
Neuropeptide S (NPS) is a recently discovered peptide signalling through its receptor NPSR, which is expressed throughout the brain. Since NPSR activation increases dopaminergic transmission, we now tested if NPSR modulates behavioural and neurochemical alterations displayed by an animal model of attention-deficit/hyperactivity disorder (ADHD), Spontaneous Hypertensive Rats (SHR), compared to its control strain, Wistar Kyoto rats (WKY). NPS (0.1 and 1 nmol, intracerebroventricularly (icv)) did not modify the performance in the open field test in both strains; however, NPSR antagonism with [tBu-d-Gly5]NPS (3 nmol, icv) increased, per se, the total distance travelled by WKY. In the elevated plus-maze, NPS (1 nmol, icv) increased the percentage of entries in the open arms (%EO) only in WKY, an effect prevented by pretreatment with [tBu-d-Gly5]NPS (3 nmol, icv), which decreased per se the %EO in WKY and increased their number of entries in the closed arms. Immunoblotting of frontal cortical extracts showed no differences of NPSR density, although SHR had a lower NPS content than WKY. SHR showed higher activity of dopamine uptake than WKY, and NPS (1 nmol, icv) did not change this profile. Overall, the present work shows that the pattern of functioning of the NPS system is distinct in WKY and SHR, suggesting that this system may contribute to the pathophysiology of ADHD.
Collapse
Affiliation(s)
| | | | - Arlete Fernandes
- Department of Physiology and Pharmacology, Universidade Federal Fluminense, Niterói, Brazil
| | - Robertta Silva Martins
- Department of Physiology and Pharmacology, Universidade Federal Fluminense, Niterói, Brazil
| | | | | | - Rodrigo A Cunha
- CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal
| | | | - Pablo Pandolfo
- Department of Neurobiology, Universidade Federal Fluminense, Niterói, Brazil.
| |
Collapse
|
4
|
Borges-Martins VPP, Ferreira DDP, Souto AC, Oliveira Neto JG, Pereira-Figueiredo D, da Costa Calaza K, de Jesus Oliveira K, Manhães AC, de Melo Reis RA, Kubrusly RCC. Caffeine regulates GABA transport via A 1R blockade and cAMP signaling. Neurochem Int 2019; 131:104550. [PMID: 31563462 DOI: 10.1016/j.neuint.2019.104550] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2019] [Revised: 09/18/2019] [Accepted: 09/19/2019] [Indexed: 01/06/2023]
Abstract
Caffeine is the most consumed psychostimulant drug in the world, acting as a non-selective antagonist of adenosine receptors A1R and A2AR, which are widely expressed in retinal layers. We have previously shown that caffeine, when administered acutely, acts on A1R to potentiate the NMDA receptor-induced GABA release. Now we asked if long-term caffeine exposure also modifies GABA uptake in the avian retina and which mechanisms are involved in this process. Chicken embryos aged E11 were injected with a single dose of caffeine (30 mg/kg) in the air chamber. Retinas were dissected on E15 for ex vivo neurochemical assays. Our results showed that [3H]-GABA uptake was dependent on Na+ and blocked at 4 °C or by NO-711 and caffeine. This decrease was observed after 60 min of [3H]-GABA uptake assay at E15, which is accompanied by an increase in [3H]-GABA release. Caffeine increased the protein levels of A1R without altering ADORA1 mRNA and was devoid of effects on A2AR density or ADORA2A mRNA levels. The decrease of GABA uptake promoted by caffeine was reverted by A1R activation with N6-cyclohexyl adenosine (CHA) but not by A2AR activation with CGS 21680. Caffeine exposure increased cAMP levels and GAT-1 protein levels, which was evenly expressed between E11-E15. As expected, we observed an increase of GABA containing amacrine cells and processes in the IPL, also, cAMP pathway blockage by H-89 decreased caffeine mediated [3H]-GABA uptake. Our data support the idea that chronic injection of caffeine alters GABA transport via A1R during retinal development and that the cAMP/PKA pathway plays an important role in the regulation of GAT-1 function.
Collapse
Affiliation(s)
| | - Danielle Dias Pinto Ferreira
- Laboratório de Doenças Neurodegenerativas, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
| | - Arthur Cardoso Souto
- Laboratório de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Niterói, Brazil.
| | - Jessika Geisebel Oliveira Neto
- Laboratório de Fisiologia Endócrina e Metabologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Niterói, Brazil.
| | - Danniel Pereira-Figueiredo
- Laboratório de Neurobiologia da Retina, Departmento de Neurobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil.
| | - Karin da Costa Calaza
- Laboratório de Neurobiologia da Retina, Departmento de Neurobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil.
| | - Karen de Jesus Oliveira
- Laboratório de Fisiologia Endócrina e Metabologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Niterói, Brazil.
| | - Alex Christian Manhães
- Laboratório de Neurofisiologia, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
| | - Ricardo Augusto de Melo Reis
- Laboratório de Neuroquímica, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
| | - Regina Célia Cussa Kubrusly
- Laboratório de Neurofarmacologia, Departamento de Fisiologia e Farmacologia, Universidade Federal Fluminense, Niterói, Brazil.
| |
Collapse
|
5
|
Martins RS, de Freitas IG, Sathler MF, Martins VPPB, Schitine CDS, da Silva Sampaio L, Freitas HR, Manhães AC, dos Santos Pereira M, de Melo Reis RA, Kubrusly RCC. Beta-adrenergic receptor activation increases GABA uptake in adolescent mice frontal cortex: Modulation by cannabinoid receptor agonist WIN55,212-2. Neurochem Int 2018; 120:182-190. [DOI: 10.1016/j.neuint.2018.08.011] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2018] [Revised: 08/15/2018] [Accepted: 08/16/2018] [Indexed: 01/09/2023]
|
6
|
Pohl‐Guimarães F, Calaza KDC, Yamasaki EN, Kubrusly RCC, Melo Reis RA. Ethanol increases GABA release in the embryonic avian retina. Int J Dev Neurosci 2009; 28:189-94. [DOI: 10.1016/j.ijdevneu.2009.11.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2009] [Revised: 10/15/2009] [Accepted: 11/05/2009] [Indexed: 12/24/2022] Open
Affiliation(s)
- Fernanda Pohl‐Guimarães
- Laboratory of Neurochemistry, Program in Neurobiology, Biophysics Institute Carlos Chagas FilhoUFRJRio de JaneiroBrazil
| | - Karin da Costa Calaza
- Laboratory of Neurobiology of the Retina, Program in Neurosciences, Biology Institute, UFF24020140NiteróiRJBrazil
| | - Edna Nanami Yamasaki
- Laboratory of Neurobiology of the Retina, Program in Neurobiology, Biophysics Institute Carlos Chagas FilhoUFRJRio de JaneiroBrazil
| | - Regina Célia Cussa Kubrusly
- Laboratory of Neuropharmacology, Program in NeurosciencesDepartment of Physiology and PharmacologyUFFNiteróiRJBrazil
| | - Ricardo Augusto Melo Reis
- Laboratory of Neurochemistry, Program in Neurobiology, Biophysics Institute Carlos Chagas FilhoUFRJRio de JaneiroBrazil
| |
Collapse
|
7
|
De Sampaio Schitine C, Cussa Kubrusly RC, De Melo Reis RA, Yamasaki EN, De Mello MCF, De Mello FG. GABA uptake by purified avian Müller glia cells in culture. Neurotox Res 2007; 12:145-53. [DOI: 10.1007/bf03033923] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Borba JC, Henze IP, Silveira MS, Kubrusly RCC, Gardino PF, de Mello MCF, Hokoç JN, de Mello FG. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development. Brain Res Dev Brain Res 2005; 156:193-201. [PMID: 16099306 DOI: 10.1016/j.devbrainres.2005.02.016] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2004] [Revised: 02/21/2005] [Accepted: 02/27/2005] [Indexed: 11/16/2022]
Abstract
In the chick retina, dopaminergic cells are generated between embryonic days 3 and 7 (E3/E7). However, the expression of tyrosine hydroxylase (TH), the first enzyme in the catecholamine synthetic pathway, is only detected after E11/E12. During the interval comprising E7 to E12, signals conveyed by cAMP are important to determine the TH phenotype. The present study shows that pituitary adenylyl cyclase-activating polypeptide (PACAP), via cAMP, is a major endogenous component in defining the TH phenotype of retina dopaminergic cells during development. PACAP type 1 receptor and its mRNA were detected in retinas since E6. PACAP was also immunodetected in cells localized in the inner nuclear layer of retinas since E8. This peptide promoted greater than 10-fold increase in cAMP accumulation of retinas obtained from embryos since E8, an effect that was blocked by PACAP6-38 (PAC1 receptor antagonist). In cultured retina cells from E8 and E9, maintained for 6 days in vitro with 10 nM PACAP (for 5 days), the number of dopaminergic cells expressing tyrosine hydroxylase increased 2.4-fold. The cAMP analog, 8-Br-cAMP and 3-isobutyl-1-methylxanthine (IBMX, a phosphodiesterase inhibitor) also increased the number of tyrosine hydroxylase-positive cells by 4- to 6-fold. IBMX plus PACAP treatment resulted in 17-fold increase in the number of cells positive for tyrosine hydroxylase. Under this condition the amount of tyrosine hydroxylase expression, as detected by western blot analysis, was also increased. The protein kinase-A inhibitor, rp-cAMPS, significantly reduced the effect of PACAP. Our data show that this peptide is an important factor influencing the definition of the tyrosine hydroxylase phenotype of retina dopaminergic cells within a narrow window of development.
Collapse
MESH Headings
- 1-Methyl-3-isobutylxanthine/pharmacology
- 8-Bromo Cyclic Adenosine Monophosphate/pharmacology
- Age Factors
- Animals
- Animals, Newborn
- Blotting, Western/methods
- Cell Count/methods
- Cell Culture Techniques
- Chick Embryo
- Colforsin/pharmacology
- Cyclic AMP/metabolism
- Dopamine/metabolism
- Dose-Response Relationship, Drug
- Drug Interactions
- Gene Expression Regulation/drug effects
- Gene Expression Regulation/physiology
- Immunohistochemistry/methods
- Microscopy, Confocal/methods
- Nerve Growth Factors/antagonists & inhibitors
- Nerve Growth Factors/physiology
- Neurons/drug effects
- Neurons/enzymology
- Neurons/metabolism
- Neuropeptides/antagonists & inhibitors
- Neuropeptides/physiology
- Neurotransmitter Agents/antagonists & inhibitors
- Neurotransmitter Agents/physiology
- Phenotype
- Phosphodiesterase Inhibitors/pharmacology
- Pituitary Adenylate Cyclase-Activating Polypeptide
- RNA, Messenger/metabolism
- Receptors, Cell Surface/genetics
- Receptors, Cell Surface/metabolism
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
- Retina/cytology
- Retina/embryology
- Retina/enzymology
- Retina/metabolism
- Reverse Transcriptase Polymerase Chain Reaction/methods
- Time Factors
- Tyrosine 3-Monooxygenase/genetics
- Tyrosine 3-Monooxygenase/metabolism
Collapse
Affiliation(s)
- Juliana Carrazzoni Borba
- Laboratórios de Neuroquímica and Neurobiologia da Retina, Instituto de Biofísica Carlos Chagas Filho-UFRJ, Centro de Ciências da Saúde-Bloco G, Universidade Federal do Rio de Janeiro, Ilha do Fundão, Rio de Janeiro, RJ 21949-900, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Abstract
The neuromuscular systems of parasitic helminths are targets that are particularly amenable for anthelmintics. In this study, we describe a GABAergic neurotransmission in adult Schistosoma mansoni, the trematode responsible for high levels of morbidity in people living in developing countries. GABA immunoreactivity (GABA-IR) was detected in nerve cells and fibres of the cerebral ganglia and longitudinal nerve cords and the nerve plexuses ramifying throughout the parenchyma of male adult worms. In addition, strong GABA-IR was also found associated with the oral and ventral suckers as well as in testes indicating a role for GABA in fixation to the host vascular wall and spermatogenesis. The capacity to synthesize GABA from glutamate was confirmed by measurement of a glutamate decarboxylase (GAD) activity. Supporting these data, a single band with an apparent molecular weight of about 67 kDa was detected using an antibody raised against mammalian GAD. In vivo studies revealed that picrotoxin, a non-competitive antagonist of the GABAA receptor, produced a modification of the motility and locomotory behaviour of adult worms, suggesting that GABAergic signalling pathway may play a physiological role in the motonervous system of S. mansoni and could be considered as a potential target for the development of new drugs.
Collapse
Affiliation(s)
- D L Mendonça-Silva
- Departamento de Farmacologia Básica e Clinica, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro, Brazil
| | | | | | | | | |
Collapse
|